BOURSE DIRECT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 EUR | -0.71% |
|
+1.08% | +6.84% |
| 05-23 | Bourse Direct: a new ETF offer with Amundi | CF |
| 05-10 | Viel & Cie: 3% sales growth in Q1 | CF |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's enterprise value to sales, at 3.49 times its current sales, is high.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +6.84% | 322M | - | ||
| +4.26% | 76.8B | B+ | ||
| -1.21% | 61.8B | B+ | ||
| -1.94% | 42.5B | B+ | ||
| -1.93% | 36.72B | A- | ||
| +1.53% | 34.03B | B+ | ||
| -26.46% | 11.17B | A- | ||
| +14.88% | 10.16B | B+ | ||
| -2.75% | 7.56B | B+ | ||
| -32.07% | 7.54B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BSD Stock
- Ratings Bourse Direct
